Shanghai ZJ Bio-Tech Co. Ltd. A - Asset Resilience Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has an Asset Resilience Ratio of 9.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688317 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2014)
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688317 net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shanghai ZJ Bio-Tech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Shanghai ZJ Bio-Tech Co. Ltd. A.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥354.30 Million | 9.52% |
| Total Liquid Assets | CN¥354.30 Million | 9.52% |
Asset Resilience Insights
- Limited Liquidity: Shanghai ZJ Bio-Tech Co. Ltd. A maintains only 9.52% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai ZJ Bio-Tech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai ZJ Bio-Tech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Kinetic Medical Co
SHE:300326 |
Medical Devices | 28.89% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 48.75% |
|
Aroa Biosurgery Ltd
AU:ARX |
Medical Devices | 12.13% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
Annual Asset Resilience Ratio for Shanghai ZJ Bio-Tech Co. Ltd. A (2014–2014)
The table below shows the annual Asset Resilience Ratio data for Shanghai ZJ Bio-Tech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2014-12-31 | 2.64% | CN¥5.28 Million ≈ $772.52K |
CN¥199.63 Million ≈ $29.21 Million |
-- |
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.